T

    Treace Medical Concepts Inc (TMCI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $4.70
    +0.05 (+1.08%)

    Market Cap: $302.41M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(16/22)
    Avg Surprise
    -77.04%
    Streak
    10 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.25
    Range$-0.25 - $-0.25
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.23+8.0%
    60d ago$-0.24+4.0%
    30d ago$-0.24+4.0%
    7d ago$-0.24+4.0%
    Current$-0.25
    Revenue Consensus
    $48M
    Range$47M - $48M
    5 analysts
    Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.02 - $0.03
    5 analysts
    Revenue Consensus
    $70M
    Range$69M - $70M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.25---
    Jun 26
    		$-0.24$-0.30+20.00%Beat+14.3%
    Mar 26
    		$-0.28$-0.31+9.68%Beat-12.0%
    Dec 25
    		$-0.08$-0.15+48.52%Beat-4793.7%
    Sep 25
    		$-0.22$-0.27+18.52%Beat+12.0%
    Jun 25
    		$-0.28$-0.29+3.45%Beat+0.0%
    Mar 25
    		$-0.25$-0.30+16.67%Beat+10.7%
    Dec 24
    		$-0.00N/A+96.25%Beat+98.4%
    Sep 24
    		$-0.25$-0.26+3.85%Beat+10.7%
    Jun 24
    		$-0.28$-0.28+0.00%Beat-40.0%
    Mar 24
    		$-0.28$-0.31+9.68%Beat-21.7%
    Dec 23
    		$-0.10$-0.09-11.11%Miss-25.0%
    Sep 23
    		$-0.28$-0.26-7.69%Miss-27.3%
    Jun 23
    		$-0.20$-0.23+13.04%Beat+13.0%
    Mar 23
    		$-0.23$-0.24+4.17%Beat-43.8%
    Dec 22
    		$-0.08$-0.14+42.86%Beat+33.3%
    Sep 22
    		$-0.22$-0.29+24.14%Beat-83.3%
    Jun 22
    		$-0.23$-0.19-21.05%Miss-130.0%
    Mar 22
    		$-0.16$-0.17+5.88%Beat-128.6%
    Dec 21
    		$-0.12$-0.01-1968.97%Miss-300.0%
    Sep 21
    		$-0.12$-0.11-9.09%Miss-152.1%
    Jun 21
    		$-0.10$-0.13+23.08%Beat-
    Mar 21
    		$-0.07$-0.06-16.67%Miss-
    Dec 20
    		$0.06$0.00N/ABeat-
    Dec 19
    		$-0.05$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-5.74EV/EBITDA-40.95x
    Price/FCF-12.21xFCF Yield-8.19%
    Profitability
    Profit Margin-29.00%Operating Margin-33.00%
    ROE-72.00%ROIC-33.98%
    Financial Health
    Debt/Equity0.83xInterest Coverage-6.22x
    Current Ratio2.90xQuick Ratio1.95x
    Trading Statistics
    Beta1.40Avg Volume416.40K
    52-Week High$7.6352-Week Low$1.17

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.57
    SMA 20$4.61
    SMA 50$4.42
    SMA 200$2.88
    EMA 10$4.61
    EMA 20$4.56
    EMA 50$4.28
    EMA 200$3.83

    MACD

    Line: 0.08Signal: 0.09Hist: -0.00

    ADX

    ADX: 21.3+DI: 20.5-DI: 13.1

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down8.0
    PSAR$4.84

    Bollinger Bands

    Upper Band$4.92
    Lower Band$4.30
    %B Position1347%(Upper)
    Band Width0.64

    RSI (14-Day)

    Neutral
    55.1

    Momentum Oscillators

    Stoch %K52.6
    Stoch %D51.2
    Williams %R-40.8
    ROC (10d)4.4%
    Momentum0.20
    CCI (20d)46.1
    MFI (14d)37.2

    Volatility Measures

    ATR (14d)$0.32(6.8%)
    StdDev (20d)0.16
    Hist Vol71.7%(High)

    Volume Flow

    VWAP$4.69
    OBV-2.6M
    AD Line-11.8M
    CMF (20d)0.012

    Volume Metrics

    Avg Vol (20d)418.5K
    Vol Ratio0.6x
    VWMA (20d)$4.63

    Pivot Points

    R3$5.01
    R2$4.90
    R1$4.77
    Pivot Point$4.66
    S1$4.54
    S2$4.43
    S3$4.30

    Advanced Oscillators

    TSI7.61
    Ultimate Osc54.9
    KST54.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$45.38M$47.20M$62.52M$50.21M$47.39M$52.57M$68.71M$45.09M$44.45M$51.11M$62.21M$40.76M
    Cost of Revenue$9.77M$9.79M$12.12M$10.51M$9.63M$10.68M$13.23M$8.95M$8.78M$10.13M$11.47M$8.00M
    Gross Profit$35.61M$37.41M$50.40M$39.71M$37.75M$41.89M$55.48M$36.13M$35.67M$40.98M$50.74M$32.76M
    Operating Expenses$50.56M$54.57M$55.98M$55.29M$54.73M$57.48M$55.56M$51.25M$56.94M$59.88M$57.30M$50.55M
    R&D$4.38M$4.62M$4.54M$4.68M$5.50M$5.56M$5.21M$4.96M$5.16M$5.26M$4.15M$4.35M
    SG&A$15.25M$16.18M$14.53M$16.28M$16.14M$15.79M$13.61M$13.53M$14.22M$14.36M$13.45M$12.69M
    Operating Income$-14,958,000$-17,167,000$-5,922,000$-15,676,000$-16,974,000$-15,582,000$-204,000$-15,134,000$-21,382,000$-18,968,000$-6,782,000$-17,818,000
    Interest Income$445,000$501,000$527,000$634,000$775,000$841,000$899,000$1.07M$1.38M$1.53M$1.71M$1.57M
    Interest Expense$1.56M$1.57M$4.09M$1.34M$1.32M$1.31M$1.31M$1.31M$1.31M$1.32M$1.30M$1.30M
    Income Before Tax$-15,873,000$-17,961,000$-9,734,000$-16,380,000$-17,398,000$-15,922,000$-1,019,000$-15,380,000$-21,237,000$-18,552,000$-6,505,000$-17,544,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-15,873,000$-17,961,000$-9,394,000$-16,288,000$-17,398,000$-15,922,000$-501,000$-15,360,000$-21,206,000$-18,676,000$-6,281,000$-17,521,000
    EBITDA$-12,619,000$-15,726,000$-3,049,000$-12,828,000$-14,239,000$-12,994,000$1.88M$-13,136,000$-19,461,000$-17,121,000$-5,314,000$-16,547,000
    EBIT$-14,756,000$-16,892,000$-5,922,000$-15,676,000$-16,852,000$-15,452,000$-204,000$-15,134,000$-21,301,000$-18,770,000$-6,782,000$-17,818,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TMCI

    Government Contracts

    Gov Obligations (TTM)
    $1158
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    3
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 39,944 Shares of Stock

    Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace purchased 39,944 shares of the company's stock on August 20th for $4.44 per share, totaling approximately $177,351. Following this acquisition, Treace now owns 7.39 million shares. The company recently reported better-than-expected quarterly revenue of $45.38 million and an adjusted loss of $0.24 per share, surpassing analyst estimates.

    MarketBeat•8/25/26•
    Neutral

    John Treace Acquires 5,000 Shares of Treace Medical Concepts (NASDAQ:TMCI) Stock

    CEO John Treace recently acquired 5,000 shares of Treace Medical Concepts (NASDAQ:TMCI) for $21,750, increasing his total holdings to 7.39 million shares. The company's latest quarterly results surpassed revenue and EPS expectations, despite a cautious "Reduce" rating from analysts and an average price target of $5.17. Institutional investors hold a significant 84.08% stake in the medical technology firm.

    MarketBeat•8/24/26•
    Somewhat-Bullish

    Insider Buying: Treace Medical Concepts (NASDAQ:TMCI) CEO Acquires 11,000 Shares

    Treace Medical Concepts CEO John Treace recently purchased 11,000 shares of the company's stock for $47,740, increasing his direct ownership to over 7.4 million shares. Despite the CEO's increased stake and the company beating Q2 analyst estimates for revenue and EPS, institutional investors own a significant portion of the company. However, analyst sentiment remains cautious, with an average "Reduce" rating and a consensus price target of $5.17.

    MarketBeat•8/24/26•
    Neutral

    Treace Medical (TMCI) CEO adds to stake with late‑August buys

    John T. Treace, CEO and director of Treace Medical Concepts, Inc. (TMCI), purchased 55,944 shares of common stock in late August 2026 through open-market transactions. These purchases were made on August 20, 21, and 24, at weighted average prices between $4.34 and $4.44 per share, and were not conducted under a Rule 10b5-1 trading plan. The filing also detailed significant indirect holdings attributed to his spouse and various trusts, for which Mr. Treace disclaims beneficial ownership.

    Stock Titan•8/24/26•
    Bullish

    Weber Capital Management LLC ADV Takes $2.35 Billion Position in Treace Medical Concepts, Inc. $TMCI

    Weber Capital Management LLC ADV has acquired a new stake of 589,617 shares, valued at approximately $2.35 billion, in Treace Medical Concepts, Inc. This position represents 0.91% of the company and 2.0% of Weber Capital Management's portfolio. Despite cautious analyst sentiment with a "Reduce" rating, Treace Medical Concepts reported a smaller-than-expected quarterly loss and higher-than-anticipated revenue, while institutional investors collectively own 84.08% of the company's stock.

    MarketBeat•8/24/26•
    Neutral

    Frequently Asked Questions About TMCI

    Does TMCI pay dividends?
    Treace Medical Concepts Inc (TMCI) does not currently pay a regular dividend.
    What is TMCI's market cap?
    Treace Medical Concepts Inc (TMCI) has a market capitalization of $302.41M with a current stock price of $4.70.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In